INMD - InMode Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

InMode Ltd.

Tavor Building
Sha'ar Yokneam PO Box 533
Yokneam 2069206
Israel
972 4 909 6313
http://www.inmodemd.com

SectorHealthcare
IndustryMedical Devices
Full Time Employees198

Key Executives

NameTitlePayExercisedYear Born
Mr. Moshe MizrahyChairman & CEON/AN/A1953
Mr. Yair MalcaChief Financial OfficerN/AN/A1978
Dr. Michael KreindelCTO & DirectorN/AN/A1968
Mr. Shakil LakhaniPres of North AmericaN/AN/A1984
Dr. Spero TheodorouChief Medical OfficerN/AN/A1972
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. The company offers minimally-invasive aesthetic medical products for procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. InMode Ltd. offers its products directly in the United States, Canada, the United Kingdom, Spain, India, and Australia, as well as indirectly through third-party distributors internationally. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.

Corporate Governance

InMode Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.